BRAF alterations in pediatric low grade gliomas and mixed neuronal–glial tumors
- 24 April 2013
- journal article
- laboratory investigation
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 113 (3) , 353-358
Abstract
Low grade astrocytomas are the most common brain tumor in children. Recent studies have identified alterations in the BRAF serine/threonine kinase gene that result in mitogen activated protein kinase pathway activation. Herewith, we investigated the genetic changes of BRAF in pediatric low grade gliomas and their relation to pathological findings and Ki-67 proliferation index. The results showed gene fusions between KIAA1549 and BRAF in 66.7 % of tumors. The majority involved the KIAA1549–BRAF exon 16-exon 9 variant. Fusion junction between KIAA1549 exon 15 and BRAF exon 9 was found in five tumors, in which the myxoid component was the predominant. This has not been previously reported. No significant correlation was found between specific KIAA1549 and BRAF fusion junctions and Ki-67 index. All of the samples included in this study were tested for the presence of the BRAFV600E mutation, and no positive sample was found.Keywords
This publication has 26 references indexed in Scilit:
- Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomasNeuro-Oncology, 2012
- MAPK pathway activation in pilocytic astrocytomaCellular and Molecular Life Sciences, 2011
- Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pediatric Low-Grade GliomasThe Journal of Molecular Diagnostics, 2011
- Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytomaNeurology, 2009
- Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumoursBritish Journal of Cancer, 2009
- Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytomaOncogene, 2009
- No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti‐EGFR TherapiesBioMed Research International, 2009
- Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic AstrocytomasCancer Research, 2008
- BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomasJournal of Clinical Investigation, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007